Point72 Asia Singapore Pte. Ltd. Sells 750 Shares of Afya Limited (NASDAQ:AFYA)

Point72 Asia Singapore Pte. Ltd. reduced its position in shares of Afya Limited (NASDAQ:AFYAFree Report) by 21.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,752 shares of the company’s stock after selling 750 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Afya were worth $49,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Marshall Wace LLP lifted its holdings in Afya by 41.8% during the 2nd quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock valued at $5,948,000 after purchasing an additional 99,416 shares during the last quarter. Doma Perpetual Capital Management LLC bought a new position in Afya during the 4th quarter valued at about $6,467,000. Millennium Management LLC lifted its holdings in Afya by 45.0% during the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock valued at $5,139,000 after purchasing an additional 90,383 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in Afya by 19.7% during the 2nd quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock valued at $4,704,000 after purchasing an additional 43,800 shares during the last quarter. Finally, Cubist Systematic Strategies LLC lifted its holdings in Afya by 136.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock valued at $622,000 after purchasing an additional 20,370 shares during the last quarter. 88.02% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on AFYA shares. UBS Group started coverage on shares of Afya in a research report on Friday, August 30th. They issued a “neutral” rating and a $19.50 price objective for the company. Morgan Stanley lowered their price objective on shares of Afya from $21.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, June 21st.

View Our Latest Stock Report on AFYA

Afya Stock Up 1.3 %

Shares of NASDAQ:AFYA opened at $16.94 on Friday. Afya Limited has a one year low of $14.57 and a one year high of $22.48. The company has a 50 day moving average of $17.13 and a 200-day moving average of $17.49. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.47 and a quick ratio of 1.47. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of 15.83, a P/E/G ratio of 0.45 and a beta of 0.92.

Afya (NASDAQ:AFYAGet Free Report) last issued its quarterly earnings results on Thursday, August 15th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.35 by $0.06. Afya had a net margin of 18.12% and a return on equity of 18.82%. The company had revenue of $155.40 million during the quarter, compared to analysts’ expectations of $151.83 million. On average, sell-side analysts forecast that Afya Limited will post 1.52 earnings per share for the current year.

Afya Company Profile

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

See Also

Want to see what other hedge funds are holding AFYA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Afya Limited (NASDAQ:AFYAFree Report).

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.